Brind.

Haleon operates within the UK market and is part of the UK Pharmaceuticals industry.

4 reports, 2 independent Updated Sep 6
Gone quiet
Reports
4
Developments
2
Repetition
50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Haleon operates within the UK market and is part of the UK Pharmaceuticals industry.

Who's involved

What this event is mainly about
Haleon

How it developed

Newest first. Tap a step to see who reported it.
  1. Haleon, a UK-based company, is being covered by research reports from Morgan Stanley and Jefferies.1 source
  2. Haleon operates in the UK market and is part of the UK Pharmaceuticals industry.1 source

Keep exploring

The entities involved

  • Haleon

    British multinational consumer healthcare company

    Nothing else this week.

Related events

Coverage

Newest first; wire copies grouped
  • tickerreport.com
  • Simply Wall St.Haleon First Half 2025 Earnings: EPS: UK£0.089 (vs UK£0.079 in 1H 2024) Revenue: UK£5.48b (down 3.8% from 1H 2024). Net income: UK£806.0m (up 11% from 1H 2024). Profit margin: 15% (up from 13% in 1H
  • Unknown outlet
  • Unknown outlet